Skip to content

Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study

Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04064177
Acronym
NICCOM
Enrollment
148
Registered
2019-08-21
Start date
2019-10-24
Completion date
2024-12-31
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Cardiac Output, High, Cardiac Output, Low

Keywords

Blood Pressure

Brief summary

This is an observational study in newborn term and preterm infants. The study will validate if non-invasive continuous cardiac output monitoring is feasible in newborn infants, if normative values can be constructed and what is the effect of fluid boluses and inotropes on cardiac output and peripheral vascular resistance.

Detailed description

This is a 3-year prospective observational study. Principal research question: Is non-invasive continuous cardiac output (CO) measurement a validated tool of comprehensive cardiovascular assessment in neonatal intensive care (NICU)? Secondary research questions: 1. Can robust normal ranges of CO be constructed for neonates undergoing cardiovascular measurement? 2. How do neonatal interventions (fluid boluses, ventilation and inotropes) affect CO? 3. Does the Non-invasive continuous cardiac output monitoring in children with foetal growth restriction (FGR) differ from normative CO data as above (1)? A prospective study of stable newborn babies in the postnatal ward and sick term and preterm infants in the NICU in 36 months.

Interventions

DEVICENICAS cardiac output monitor

Non-invasive continuous cardiac output monitoring device using total body bioimpedance.

Sponsors

Imperial College Healthcare NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* Healthy term infants in postnatal ward (within the first 72 hours of age) * Term and Preterm infants (including those with FGR) admitted to the neonatal unit * Written informed parental consent (prospective for postnatal ward and retrospective for babies admitted to the neonatal units)

Exclusion criteria

* Antenatal or postnatal diagnosis of severe congenital anomaly * Infants with no realistic chance of survival * Infants who are \>12 hours of age * Infants with fragile skin not permitting skin probe placement

Design outcomes

Primary

MeasureTime frameDescription
Changes in cardiac output36 monthsChanges in cardiac output (CO) measurement (mls/kg/min) in relation to neonatal intervention
Haemodynamic outcome comparison to echocardiography measured CO36 monthsNon-invasive continuous Cardiac Output (CO) measurement (mls/kg/min) during the first month of life in comparison to echocardiography measured CO (mls/kg/min)

Secondary

MeasureTime frameDescription
Changes in clinical outcome - Survival at discharge36 monthsSurvival at discharge

Countries

United Kingdom

Contacts

Primary ContactJayanta Banerjee Imperial College Healthcare NHS Trust
jayanta.banerjee@nhs.net02033137308
Backup ContactSundar Sathiyamurthy Imperial College Healthcare NHS Trust
s.sathiyamurthy@nhs.net02033137308

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026